Match!

Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells

Published on Feb 1, 2020in The Journal of Allergy and Clinical Immunology
· DOI :10.1016/j.jaci.2019.08.029
Marie Pouzolles2
Estimated H-index: 2
(University of Montpellier),
Alice Machado1
Estimated H-index: 1
(University of Montpellier)
+ 14 AuthorsValérie S. Zimmermann18
Estimated H-index: 18
(University of Montpellier)
Abstract
Background Patients with T-cell immunodeficiencies are generally treated with allogeneic hematopoietic stem cell transplantation, but alternatives are needed for patients without matched donors. An innovative intrathymic gene therapy approach that directly targets the thymus might improve outcomes. Objective We sought to determine the efficacy of intrathymic adeno-associated virus (AAV) serotypes to transduce thymocyte subsets and correct the T-cell immunodeficiency in a zeta-associated protein of 70 kDa (ZAP-70)–deficient murine model. Methods AAV serotypes were injected intrathymically into wild-type mice, and gene transfer efficiency was monitored. ZAP-70−/− mice were intrathymically injected with an AAV8 vector harboring the ZAP70 gene. Thymus structure, immunophenotyping, T-cell receptor clonotypes, T-cell function, immune responses to transgenes and autoantibodies, vector copy number, and integration were evaluated. Results AAV8, AAV9, and AAV10 serotypes all transduced thymocyte subsets after in situ gene transfer, with transduction of up to 5% of cells. Intrathymic injection of an AAV8–ZAP-70 vector into ZAP-70−/− mice resulted in a rapid thymocyte differentiation associated with the development of a thymic medulla. Strikingly, medullary thymic epithelial cells expressing the autoimmune regulator were detected within 10 days of gene transfer, correlating with the presence of functional effector and regulatory T-cell subsets with diverse T-cell receptor clonotypes in the periphery. Although thymocyte reconstitution was transient, gene-corrected peripheral T cells harboring approximately 1 AAV genome per cell persisted for more than 40 weeks, and AAV vector integration was detected. Conclusions Intrathymic AAV-transduced progenitors promote a rapid restoration of the thymic architecture, with a single wave of thymopoiesis generating long-term peripheral T-cell function.
  • References (144)
  • Citations (1)
📖 Papers frequently viewed together
5 Authors (Ou Cao, ..., Roland W. Herzog)
42 Citations
25 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References144
Newest
Abstract Background Allogeneic hematopoietic stem-cell transplantation for X-linked severe combined immunodeficiency (SCID-X1) often fails to reconstitute immunity associated with T cells, B cells,...
12 CitationsSource
#1Byron B. Au-YeungH-Index: 15
#2Neel H. ShahH-Index: 14
Last. Arthur WeissH-Index: 108
view all 4 authors...
T cells possess an array of functional capabilities important for host defense against pathogens and tumors. T cell effector functions require the T cell antigen receptor (TCR). The TCR has no intr...
9 CitationsSource
#1Felix F. Reichel (University of Tübingen)H-Index: 3
#2Tobias Peters (University of Tübingen)H-Index: 15
Last. M. Dominik FischerH-Index: 16
view all 10 authors...
PURPOSE. To study longitudinal changes of anti-drug antibody (ADA) titers to recombinant adeno-associated virus serotype 8 (rAAV8) capsid epitopes in nonhuman primates (NHP) and patients. METHODS. Three groups of six NHP each received subretinal injections (high dose: 1 x 10(12) vector genomes [vg], low dose: 1 x 10(11) vg, or vehicle only). Four additional animals received intravitreal injections of the high dose (1 x 10(12) vg). Three patients received 1 x 10(10) vg as subretinal injections. E...
6 CitationsSource
#1Pasqualina Colella (French Institute of Health and Medical Research)H-Index: 1
#2Giuseppe Ronzitti (French Institute of Health and Medical Research)H-Index: 9
Last. Federico Mingozzi (French Institute of Health and Medical Research)H-Index: 11
view all 3 authors...
In recent years, the number of clinical trials in which adeno-associated virus (AAV) vectors have been used for in vivo gene transfer has steadily increased. The excellent safety profile, together with the high efficiency of transduction of a broad range of target tissues, has established AAV vectors as the platform of choice for in vivo gene therapy. Successful application of the AAV technology has also been achieved in the clinic for a variety of conditions, including coagulation disorders, in...
72 CitationsSource
#1Felix F. ReichelH-Index: 3
Last. M. Dominik FischerH-Index: 16
view all 13 authors...
Ocular gene therapy has evolved rapidly into the clinical realm due to promising pre-clinical proof-of-concept studies, recognition of the high unmet medical need of blinding disorders, and the excellent safety profile of the most commonly used vector system, the adeno-associated virus (AAV). With several trials exposing subjects to AAV, investigators independently report about cases with clinically evident inflammation in treated eyes despite the concept of ocular immune privilege. Here, we pro...
16 CitationsSource
#1Caroline Le Guiner (University of Nantes)H-Index: 17
#2Laurent ServaisH-Index: 21
Last. George Dickson (RHUL: Royal Holloway, University of London)H-Index: 47
view all 35 authors...
Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease caused by mutations in the dystrophin gene. Gene therapy using highly functional microdystrophin genes and recombinant adeno-associated virus (rAAV) vectors is an attractive strategy to treat DMD. Here we show that locoregional and systemic delivery of a rAAV2/8 vector expressing a canine microdystrophin (cMD1) is effective in restoring dystrophin expression and stabilizing clinical symptoms in studies performed on...
48 CitationsSource
#1Andrea Z. Tuckett (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 5
#2Raymond H. Thornton (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 26
Last. Johannes L. Zakrzewski (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 16
view all 5 authors...
Background Even though hematopoietic stem cell transplantation can be curative in patients with severe combined immunodeficiency, there is a need for additional strategies boosting T cell immunity in individuals suffering from genetic disorders of lymphoid development. Here we show that image-guided intrathymic injection of hematopoietic stem and progenitor cells in NOD-scid IL2rγnull mice is feasible and facilitates the generation of functional T cells conferring protective immunity.
3 CitationsSource
Background Omenn syndrome (OS) is a rare severe combined immunodeficiency associated with autoimmunity and caused by defects in lymphoid-specific V(D)J recombination. Most patients carry hypomorphic mutations in recombination-activating gene ( RAG ) 1 or 2. Hematopoietic stem cell transplantation is the standard treatment; however, gene therapy (GT) might represent a valid alternative, especially for patients lacking a matched donor. Objective We sought to determine the efficacy of lentiviral ve...
7 CitationsSource
#1Matthew Elverman (UW: University of Washington)H-Index: 2
#2Melissa A. Goddard (Wake Forest University)H-Index: 7
Last. Martin K. Childers (UW: University of Washington)H-Index: 25
view all 13 authors...
Introduction X-linked myotubular myopathy (XLMTM), a devastating pediatric disease caused by the absence of the protein myotubularin, results from mutations in the MTM1 gene. While there is no cure for XLMTM, we previously reported effects of MTM1 gene therapy using adeno-associated virus (AAV) vector on muscle weakness and pathology in MTM1-mutant dogs. Here, we followed 2 AAV-infused dogs over 4 years. Methods We evaluated gait, strength, respiration, neurological function, muscle pathology, A...
20 CitationsSource
#1Ruth EtzenspergerH-Index: 8
#2Tejas KadakiaH-Index: 3
Last. Alfred SingerH-Index: 63
view all 8 authors...
T cells developing in the thymus are signaled during positive selection to differentiate into either CD4+ T cells or CD8+ T cells. Singer and colleagues show that CD8+-lineage specification is signaled exclusively by cytokines, including cytokines that do not signal via the γc receptor, and that these are the only signals in the thymus that upregulate the transcription factor Runx3d to direct specification to the CD8+ lineage.
11 CitationsSource
Cited By1
Newest
Source